Correlation Between Nuvectis Pharma and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Nuvectis Pharma and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Cadrenal Therapeutics,.
Diversification Opportunities for Nuvectis Pharma and Cadrenal Therapeutics,
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nuvectis and Cadrenal is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Cadrenal Therapeutics,
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 1.05 times less return on investment than Cadrenal Therapeutics,. In addition to that, Nuvectis Pharma is 1.11 times more volatile than Cadrenal Therapeutics, Common. It trades about 0.22 of its total potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about 0.26 per unit of volatility. If you would invest 1,550 in Cadrenal Therapeutics, Common on November 3, 2024 and sell it today you would earn a total of 427.00 from holding Cadrenal Therapeutics, Common or generate 27.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvectis Pharma vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Nuvectis Pharma |
| Cadrenal Therapeutics, |
Nuvectis Pharma and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Cadrenal Therapeutics,
The main advantage of trading using opposite Nuvectis Pharma and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |